Rhumbline Advisers Olink Holding Ab (Publ) Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$21.87 - $25.59 $5,708 - $6,678	261 Added 12.55%	2,340 $59,000
Q1 2024 May 09, 2024	BUY	$21.81 - $25.14 $6,237 - $7,190	286 Added 15.95%	2,079 $48,000
Q4 2023 Feb 08, 2024	BUY	$14.29 - $25.95 $6,501 - $11,807	455 Added 34.01%	1,793 $45,000
Q3 2023 Nov 09, 2023	BUY	$14.45 - $20.34 $144 - $203	10 Added 0.75%	1,338 $19,000
Q2 2023 Aug 08, 2023	BUY	$17.13 - $23.74 $22,748 - $31,526	1,328 New	1,328 $24,000

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.